» Articles » PMID: 35777721

Exertional Dyspnoea Responses Reported in the Dyspnoea Challenge and Measures of Disease Severity in COPD

Overview
Specialty Pulmonary Medicine
Date 2022 Jul 1
PMID 35777721
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The Dyspnoea Challenge has been developed to facilitate the field-based measure of exertional dyspnoea(ED). To further validate the test, we aimed to; investigate the relationship between end-exercise ED, generated by a fixed-intensity Dyspnoea Challenge(DC), and measures of disease severity (Forced expiratory volume in 1 s(FEV), six-minute walk distance(6MWD), breathing reserve(V̇/MVV), modified medical research council dyspnoea scale (mMRC), Body-mass index, airflow Obstruction, Dyspnoea, and Exercise (BODE index) and compare the physiological response of the DC to a six-minute walk test(6MWT).

Methods: Thirty-two individuals (15 female) with COPD (GOLD II-IV) (age: 69.7 ± 9.4 yrs; FEV: 49.1 ± 18.2 %) performed 2×6MWT and 2xDC at a treadmill speed of 3 km h and gradient of 4 %. The intensity of ED was measured using the modified Borg dyspnoea scale at baseline and end-exercise with heart rate (HR) and oxygen saturation (SO) monitored continuously. During 1×6MWT and 1xDC pulmonary gas exchange, cardiac output (Q̇) and dynamic hyperinflation were measured.

Results: End-exercise ED measured during the DC was not correlated to FEV, but moderately correlated to; 6MWD(r = -0.54, P < .01), V̇/MVV (r = 0.46, P = .02), mMRC(r = 0.45, P = .01), and the BODE index(r = 0.53, P < .01). When comparing the DC and 6MWT, participants walked to comparable levels of oxygen consumption(P = .38), ventilation(P = .37), Q̇(P = .20), V̇/MVV(P = .83), maximum HR percentages(P = .67) and dynamically hyperinflated to a similar degree(P = .37).

Conclusions: The Dyspnoea Challenge is correlated to different parameters of disease severity and produces a similar physiological and ED response to that of the 6MWT with the added benefit of being appropriate for longitudinal assessment of ED.

Citing Articles

Fixed-intensity exercise tests to measure exertional dyspnoea in chronic heart and lung populations: a systematic review.

Palmer T, Obst S, Aitken C, Walsh J, Sabapathy S, Adams L Eur Respir Rev. 2023; 32(169).

PMID: 37558262 PMC: 10410401. DOI: 10.1183/16000617.0016-2023.


Is it time to include oxygen needs as an endpoint in clinical trials in patients with fibrosing interstitial lung disease? If so, how?.

Aronson K, Jacobs S, Repola D, Swigris J BMJ Open Respir Res. 2023; 10(1).

PMID: 37419519 PMC: 10347448. DOI: 10.1136/bmjresp-2022-001546.